https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

Alterations in serum magnesium levels are presented as a new risk factor in liver disease

3 de March de 2021

Individuals with alterations in magnesium levels have an increased risk of presenting fatty liver disease with inflammation and fibrosis, as concluded by a study that has just been published in Journal of Hepatology. Non-alcoholic steatohepatitis, characterized by inflammation and liver fibrosis, is associated with obesity and has a worldwide prevalence of 1.7 billion people. Unhealthy […]

Read more →

Cantabria Cohorte study will monitor 50000 people

1 de March de 2021

Cohorte Cantabria will allow to know in depth the characteristics of the population of Cantabria and its behavior in key aspects for health such as lifestyle habits, risk factors for getting sick, the causes of the main diseases and, even more importantly, favoring development of personalized, predictive and preventive medicine. These are the main objectives […]

Read more →

The PsicAP study proposes adding a psychological treatment in PC

The PsicAP project is the largest mental health care clinical trial ever conducted in Spain to date, about the efficacy of psychological treatment for people with emotional disorders in Primary Care (PC). The study has just published its results in the journal Psychological Medicine. The results confirm that adding a group psychological treatment of 7 […]

Read more →

Resistance test in the Cantabrian Health Service against COVID-19

14 de December de 2020

The crisis generated by the pandemic derived from COVID-19 in extreme contingency scenarios presents a terrible dilemma: first, it is to protect the health of citizens, although that can hibernate the economy and cause a reduction in income with unequal effects by socioeconomic gradient and by Regional Health Service. In this sense, the Transversal Group […]

Read more →

Lung Transplant Patients With COVID-19

10 de December de 2020

Recently, a multicenter retrospective has been published in the American Journal of Transplantation in which six of the seven hospitals that perform lung transplantation in Spain have participated and which are the following: Vall d'Hebron (Barcelona), La Fe (Valencia) , Marqués de Valdecilla (Santander), Reina Sofía (Córdoba), Puerta de Hierro (Madrid), October 12 (Madrid), and […]

Read more →

First results of immunological inflammatory diseases and SARS-CoV-2

8 de September de 2020

The Marqués de Valdecilla University Hospital Rheumatology Unit, in collaboration with the Valdecilla Health Research Institute (IDIVAL), has launched a study to determine the relationship between immunological inflammatory diseases and SARS-CoV-2. Developed by doctors Ricardo Blanco, Miguel Ángel González-Gay and David Martínez-López, the objectives of this research in patients with rheumatological diseases with an immune […]

Read more →

Valdecilla participates in an international study investigating a vaccine against Coronavirus

28 de August de 2020

The Marqués de Valdecilla University Hospital has been one of the 3 Spanish hospitals selected to participate in an international study investigating a vaccine, Ad26COVS, against the SARS-CoV-2 coronavirus, which is responsible for the COVID-19 disease. Thanks to the collaboration of healthy volunteers, the aim is to evaluate the immune response to different doses of […]

Read more →

Seroprevalence against COVID-19 in pregnant women and newborns

24 de August de 2020

The ISCIII through the extraordinary call for research projects on SARS-COV-2 and the Covid-19 disease has financed the project “Seroprevalence against SARS-CoV-2 in pregnant women and newborns” directed by Dr. Cabero -Head of the Pediatrics Service- and Dr. Llorca -Professor of Preventive Medicine and Public Health-. This project aims to know the impact that COVID-19 […]

Read more →

New devices for the surgical treatment of glioblastoma

20 de August de 2020

The multidisciplinary work team formed by the group of Cell Signaling and Therapeutic Targets in Cancer of IDIVAL; the Optics group of the University of Cantabria (UC) and the Neurosurgery service of the Marqués de Valdecilla University Hospital (HUMV); Together with the company Fotoglass, specialized in biomedical optics, a spin off of UC, they have […]

Read more →

Melatonin as a radio-sensitizer in cancer

18 de August de 2020

The research group "Melatonin and Breast Cancer" of IDIVAL has recently published in the journal Biomedicines, with impact factor Q1, the article "Melatonin as a Radio-Sensitizer in Cancer". Radiotherapy is one of the treatments of choice in many types of cancer. Adjuvant treatments to radiotherapy try, on one hand, to enhance the response of tumor […]

Read more →